Skip to main content
Clinical Trials/NCT04970953
NCT04970953
Terminated
Not Applicable

Prospective Analysis of Diastolic Stress Tests to Detect Exercise Induced Heart Failure With Preserved Ejection Fraction (HFpEF) in Patients With Intermediate Risk (DEST-HF Study, Diastolic Exercise Stress Testing in Heart Failure)

University Hospital, Essen1 site in 1 country19 target enrollmentAugust 9, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure With Preserved Ejection Fraction
Sponsor
University Hospital, Essen
Enrollment
19
Locations
1
Primary Endpoint
PAWP increase across the four stress tests
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

Patients with an intermediate risk (HFA-PEFF score 2-4 points) for heart failure with preserved ejection fraction (HFpEF) will be further investigated with invasive right heart catheterization. All patients with a resting pulmonary artery wedge pressure (PAWP) <15mmHg will undergo the following stress test modalities in a randomized order: (1) bicycle ergometry, (2) dynamic handgrip exercise, (3) 500ml fluid challenge over 5 minutes, (4) leg raise testing. Exercise induced HFpEF will be diagnosed if PAWP rises to >25mmHg.

Detailed Description

Patients reporting to the investigators' clinic for in- and outpatient consultation and a HFA-PEFF score of 2-4 points will be recruited if their dyspnea is not sufficiently explained by other causes than HFpEF. Patients will undergo a baseline clinical exam, transthoracic echocardiography with measurement of diastolic parameters, and ECG. NYHA class will be reported, standard lab works (NTproBNP, GFR, CRP, Hb, PLT, blood gas analysis) will be taken. The number of patients with a PAWP increase in right heart catheterization (brachial access under sonographic guidance) from a resting value of \<15mmHg to \>25mmHg during stress testing will be assessed across the four interventions. During bicycle ergometry (semi-supine position) spiroergometric data and gas exchange variables (cardiopulmonary exercise testing) will be co-assessed. Between the testing modalities a 10-minute break will allow hemodynamic variables to normalize.

Registry
clinicaltrials.gov
Start Date
August 9, 2021
End Date
February 20, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Essen
Responsible Party
Principal Investigator
Principal Investigator

Peter Lüdike

Professor of Cardiology

University Hospital, Essen

Eligibility Criteria

Inclusion Criteria

  • Age \> 18 years
  • Unclear etiology of dyspnea with non-invasive testing
  • HFA-PEFF score 2-4 points and thus an intermediate risk for HFpEF
  • Willingness to participate and obtained written consent

Exclusion Criteria

  • Consent for study participation not obtained
  • Age \< 18 years
  • Medical contraindications to perform right heart catheterization

Outcomes

Primary Outcomes

PAWP increase across the four stress tests

Time Frame: 1 year

Number of patients with an increase of PAWP\<15mmHg at rest to \>25mmHg during stress testing.

Secondary Outcomes

  • Association of PAWP increase and changes of VO2peak during bicycle ergometry(1 year)
  • Changes of pulmonary vascular resistance (PVR) across the four stress tests(1 year)
  • Changes of mean pulmonary artery pressure (mPAP) across the four stress tests(1 year)

Study Sites (1)

Loading locations...

Similar Trials